Patent assignee · FR · COMPANY

SANOFI BIOTECHNOLOGY

🏢 View company profile →
35Patents
35Active
35Granted
55Portfolio score

Filing activity: Jan 27, 2012 → Sep 21, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US9574004B2 Methods for treating or preventing asthma by administering an IL-4R antagonist Physics 32 Active
US10485844B2 Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor Chemistry; Metallurgy 20 Active
US10059771B2 Methods for treating nasal polyposis by administering an IL-4R antagonist Chemistry; Metallurgy 18 Active
US10137193B2 Methods for treating or preventing asthma by administering an IL-4R antagonist Chemistry; Metallurgy 17 Active
US10066017B2 Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist Chemistry; Metallurgy 17 Active
US9561155B2 Method of reducing cholesterol levels using a human anti-PCSK9 antibody Chemistry; Metallurgy 14 Active
US10370449B2 Methods for treating skin infection by administering an IL-4R antagonist Chemistry; Metallurgy 12 Active
US11034768B2 Methods for treating or preventing asthma by administering an IL-4R antagonist Chemistry; Metallurgy 12 Active
US11053309B2 Methods for treating active eosinophilic esophagitis Chemistry; Metallurgy 10 Active
US9682013B2 Pharmaceutical compositions comprising human antibodies to PCSK9 Chemistry; Metallurgy 9 Active
US10544232B2 Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Chemistry; Metallurgy 7 Active
US10494442B2 Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9 Emerging Cross-Sectional Technologies 7 Active
US9943594B2 Methods for the treatment of rheumatoid arthritis Human Necessities 6 Active
US10428157B2 Dosing regimens for use with PCSK9 inhibitors Chemistry; Metallurgy 6 Active
US10927435B2 Compositions for the treatment of rheumatoid arthritis and methods of using same Chemistry; Metallurgy 5 Active
US11246925B2 Human antibodies to PCSK9 for use in methods of treating particular groups of subjects Chemistry; Metallurgy 4 Active
US11639392B2 Anti-IL-1R3 antibodies for use in inflammatory conditions Chemistry; Metallurgy 4 Active
US10995150B2 Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody Emerging Cross-Sectional Technologies 4 Active
US11306155B2 Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody Chemistry; Metallurgy 4 Active
US11214621B2 Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist Chemistry; Metallurgy 2 Active
US11845800B2 Methods for treating or preventing asthma by administering an IL-4R antagonist Physics 1 Active
US11498969B2 Compositions and methods for treating juvenile idiopathic arthritis Emerging Cross-Sectional Technologies 1 Active
US11771743B2 Methods for preventing or treating allergy by administering an IL-4R antagonist Chemistry; Metallurgy 1 Active
US10968278B2 Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same Chemistry; Metallurgy 1 Active
US12024564B2 Humanized anti-IL-1R3 antibodies Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.